Insider Transactions in Q4 2021 at Vyant Bio, Inc. (VYNT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2021
|
Marcus Boehm Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+3.74%
|
$5,000
$1.69 P/Share
|
|
Nov 24
2021
|
John A Roberts Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+11.16%
|
$10,000
$2.02 P/Share
|
|
Nov 23
2021
|
Andrew D.C. La Frence Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+12.71%
|
$10,000
$2.0 P/Share
|
|
Nov 22
2021
|
Yung Ping Yeh Director |
BUY
Open market or private purchase
|
Direct |
500
+3.77%
|
$1,000
$2.05 P/Share
|
|
Nov 09
2021
|
Paul R. Hansen Director |
BUY
Acquisition or disposition by will or laws
|
Direct |
6,783
+4.07%
|
-
|
|
Oct 28
2021
|
Robert Thomas Fremeau Jr. Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$2,000
$2.19 P/Share
|
|
Oct 27
2021
|
Marcus Boehm Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+3.88%
|
$10,000
$2.1 P/Share
|